Sandra Fernandes Denney

Title: Innovations of Sandra Fernandes Denney

Introduction

Sandra Fernandes Denney is a notable inventor based in Constantia, NY (US). She has made significant contributions to the field of biotechnology, particularly in the development of methods and kits for detecting specific messenger RNA transcripts and polypeptides. With a total of 2 patents, her work has the potential to impact medical diagnostics and cancer treatment.

Latest Patents

One of her latest patents is titled "Methods and kits for detecting a fusion messenger RNA transcript or a polypeptide encoded by the fusion messenger RNA transcript." This invention relates to methods that involve obtaining a biological sample from a subject and using reagents capable of binding to a fusion mRNA transcript or the corresponding polypeptide. The fusion mRNA transcript comprises the 3' end of exon 25 of INPP5D fused to the 5' end of exon 2 of ATG16L1. Another significant patent is "Tryptamine-based ship inhibitors for the treatment of cancer." This disclosure provides compositions that inhibit the SH2-containing inositol 5'-phosphatase (SHIP) and outlines methods for using these compositions to treat or ameliorate medical conditions in subjects.

Career Highlights

Sandra has worked with esteemed institutions such as the State University of New York and Syracuse University. Her academic and research background has provided her with a solid foundation to innovate in her field.

Collaborations

Throughout her career, Sandra has collaborated with notable individuals, including William Garrow Kerr and Frank A Middleton. These collaborations have likely contributed to her success and the advancement of her inventions.

Conclusion

Sandra Fernandes Denney is a pioneering inventor whose work in biotechnology is paving the way for advancements in medical diagnostics and cancer treatment. Her contributions are significant and reflect her dedication to innovation in her field.